Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders L Carlson

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Diabetes Technology & Therapeutics|August 8, 2025
A Multicenter Study of an Investigational Extended Wear Insulin Infusion Set in Adults with Type 1 DiabetesRayhan A Lal, John W Lum, Zachariah W Reed, et al.
Diabetes Technology & Therapeutics|October 18, 2023
Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 DiabetesAmy B Criego, Anders L Carlson, Sue A Brown, et al.
Diabetes Technology & Therapeutics|October 2, 2023
Safety and Glycemic Outcomes During the MiniMed<sup>TM</sup> Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 DiabetesCatherine Pihoker, Dorothy I Shulman, Gregory P Forlenza, et al.
Diabetes Care|June 8, 2021
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 DiabetesSue A Brown, Gregory P Forlenza, Bruce W Bode, et al.
Diabetes Technology & Therapeutics|October 25, 2021
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 DiabetesAnders L Carlson, Jennifer L Sherr, Dorothy I Shulman, et al.
JAMA Network Open|February 14, 2025
Automated Insulin Delivery in Adults With Type 2 Diabetes: A Nonrandomized Clinical TrialFrancisco J Pasquel, Georgia M Davis, David M Huffman, et al.
Diabetes Technology & Therapeutics|June 5, 2026
Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe UseSatish K Garg, Halis K Akturk, Samita Garg, et al.
Diabetes Technology & Therapeutics|August 18, 2025
Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One SensorLaura M Nally, Jennifer L Sherr, Satish K Garg, et al.
Diabetes Technology & Therapeutics|December 6, 2022
Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled TrialSatish K Garg, George Grunberger, Ruth Weinstock, et al.
Frontiers in Endocrinology|January 5, 2026
Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trialJohan H Jendle, Satish K Garg, Charles Thivolet, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Diabetes Technology & Therapeutics|August 8, 2025
A Multicenter Study of an Investigational Extended Wear Insulin Infusion Set in Adults with Type 1 DiabetesRayhan A Lal, John W Lum, Zachariah W Reed, et al.
Diabetes Technology & Therapeutics|October 18, 2023
Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 DiabetesAmy B Criego, Anders L Carlson, Sue A Brown, et al.
Diabetes Technology & Therapeutics|October 2, 2023
Safety and Glycemic Outcomes During the MiniMed<sup>TM</sup> Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 DiabetesCatherine Pihoker, Dorothy I Shulman, Gregory P Forlenza, et al.
Diabetes Care|June 8, 2021
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 DiabetesSue A Brown, Gregory P Forlenza, Bruce W Bode, et al.
Diabetes Technology & Therapeutics|October 25, 2021
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 DiabetesAnders L Carlson, Jennifer L Sherr, Dorothy I Shulman, et al.
JAMA Network Open|February 14, 2025
Automated Insulin Delivery in Adults With Type 2 Diabetes: A Nonrandomized Clinical TrialFrancisco J Pasquel, Georgia M Davis, David M Huffman, et al.
Diabetes Technology & Therapeutics|June 5, 2026
Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe UseSatish K Garg, Halis K Akturk, Samita Garg, et al.
Diabetes Technology & Therapeutics|August 18, 2025
Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One SensorLaura M Nally, Jennifer L Sherr, Satish K Garg, et al.
Diabetes Technology & Therapeutics|December 6, 2022
Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled TrialSatish K Garg, George Grunberger, Ruth Weinstock, et al.
Frontiers in Endocrinology|January 5, 2026
Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trialJohan H Jendle, Satish K Garg, Charles Thivolet, et al.
Pageof 6